371 related articles for article (PubMed ID: 8974314)
1. Polymorphisms of the D2 dopamine receptor gene and alcoholism and other substance use disorders.
Noble EP
Alcohol Alcohol Suppl; 1994; 2():35-43. PubMed ID: 8974314
[TBL] [Abstract][Full Text] [Related]
2. Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: a review.
Noble EP
Eur Psychiatry; 2000 Mar; 15(2):79-89. PubMed ID: 10881203
[TBL] [Abstract][Full Text] [Related]
3. Recent developments in alcoholism:molecular biology and behavior.
Noble EP; Paredes A
Recent Dev Alcohol; 1993; 11():345-62. PubMed ID: 7901878
[TBL] [Abstract][Full Text] [Related]
4. Alcoholism and the dopaminergic system: a review.
Noble EP
Addict Biol; 1996; 1(4):333-48. PubMed ID: 12893451
[TBL] [Abstract][Full Text] [Related]
5. Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D₂ agonist therapy: part 2.
Blum K; Chen TJ; Morse S; Giordano J; Chen AL; Thompson J; Allen C; Smolen A; Lubar J; Stice E; Downs BW; Waite RL; Madigan MA; Kerner M; Fornari F; Braverman ER
Postgrad Med; 2010 Nov; 122(6):214-26. PubMed ID: 21084796
[TBL] [Abstract][Full Text] [Related]
6. D2 dopamine receptor TaqI A alleles in medically ill alcoholic and nonalcoholic patients.
Noble EP; Syndulko K; Fitch RJ; Ritchie T; Bohlman MC; Guth P; Sheridan PJ; Montgomery A; Heinzmann C; Sparkes RS
Alcohol Alcohol; 1994 Nov; 29(6):729-44. PubMed ID: 7695792
[TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase-A polymorphisms might modify the association between the dopamine D2 receptor gene and alcohol dependence.
Huang SY; Lin WW; Wan FJ; Chang AJ; Ko HC; Wang TJ; Wu PL; Lu RB
J Psychiatry Neurosci; 2007 May; 32(3):185-92. PubMed ID: 17476365
[TBL] [Abstract][Full Text] [Related]
8. The D2 dopamine receptor gene: a review of association studies in alcoholism and phenotypes.
Noble EP
Alcohol; 1998 Jul; 16(1):33-45. PubMed ID: 9650634
[TBL] [Abstract][Full Text] [Related]
9. Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).
Blum K; Chen TJ; Downs BW; Bowirrat A; Waite RL; Braverman ER; Madigan M; Oscar-Berman M; DiNubile N; Stice E; Giordano J; Morse S; Gold M
Postgrad Med; 2009 Nov; 121(6):176-96. PubMed ID: 19940429
[TBL] [Abstract][Full Text] [Related]
10. Increased prevalence of the Taq I A1 allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary report.
Blum K; Braverman ER; Wood RC; Gill J; Li C; Chen TJ; Taub M; Montgomery AR; Sheridan PJ; Cull JG
Pharmacogenetics; 1996 Aug; 6(4):297-305. PubMed ID: 8873216
[TBL] [Abstract][Full Text] [Related]
11. The DRD2 gene in psychiatric and neurological disorders and its phenotypes.
Noble EP
Pharmacogenomics; 2000 Aug; 1(3):309-33. PubMed ID: 11256581
[TBL] [Abstract][Full Text] [Related]
12. D2 dopamine receptor gene TaqI A1 and B1 restriction fragment length polymorphisms: enhanced frequencies in psychostimulant-preferring polysubstance abusers.
Persico AM; Bird G; Gabbay FH; Uhl GR
Biol Psychiatry; 1996 Oct; 40(8):776-84. PubMed ID: 8894071
[TBL] [Abstract][Full Text] [Related]
13. The D2 dopamine receptor gene: a review of association studies in alcoholism.
Noble EP
Behav Genet; 1993 Mar; 23(2):119-29. PubMed ID: 8512526
[TBL] [Abstract][Full Text] [Related]
14. Associations of the DRD2 TaqIA polymorphism with impulsivity and substance use: preliminary results from a clinical sample of adolescents.
Esposito-Smythers C; Spirito A; Rizzo C; McGeary JE; Knopik VS
Pharmacol Biochem Behav; 2009 Sep; 93(3):306-12. PubMed ID: 19344737
[TBL] [Abstract][Full Text] [Related]
15. Advances in molecular genetics and the prevention and treatment of substance misuse: Implications of association studies of the A1 allele of the D2 dopamine receptor gene.
Young RM; Lawford BR; Nutting A; Noble EP
Addict Behav; 2004 Sep; 29(7):1275-94. PubMed ID: 15345265
[TBL] [Abstract][Full Text] [Related]
16. Reward deficiency syndrome: genetic aspects of behavioral disorders.
Comings DE; Blum K
Prog Brain Res; 2000; 126():325-41. PubMed ID: 11105655
[TBL] [Abstract][Full Text] [Related]
17. An association between a functional polymorphism at the DRD2 gene and the liability to substance abuse.
Vanyukov MM
Am J Med Genet; 1999 Oct; 88(5):590-1. PubMed ID: 10490720
[No Abstract] [Full Text] [Related]
18. Acute intravenous synaptamine complex variant KB220™ "normalizes" neurological dysregulation in patients during protracted abstinence from alcohol and opiates as observed using quantitative electroencephalographic and genetic analysis for reward polymorphisms: part 1, pilot study with 2 case reports.
Miller DK; Bowirrat A; Manka M; Miller M; Stokes S; Manka D; Allen C; Gant C; Downs BW; Smolen A; Stevens E; Yeldandi S; Blum K
Postgrad Med; 2010 Nov; 122(6):188-213. PubMed ID: 21084795
[TBL] [Abstract][Full Text] [Related]
19. Family-based and case-control study of DRD2, DAT, 5HTT, COMT genes polymorphisms in alcohol dependence.
Samochowiec J; Kucharska-Mazur J; Grzywacz A; Jabłoński M; Rommelspacher H; Samochowiec A; Sznabowicz M; Horodnicki J; Sagan L; Pełka-Wysiecka J
Neurosci Lett; 2006 Dec; 410(1):1-5. PubMed ID: 17079080
[TBL] [Abstract][Full Text] [Related]
20. The TaqI A DRD2 polymorphism in type II alcohol dependence: a marker of age at onset or of a familial disease?
Pinto E; Reggers J; Gorwood P; Boni C; Scantamburlo G; Pitchot W; Ansseau M
Alcohol; 2009 Jun; 43(4):271-5. PubMed ID: 19376678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
